Archives

Malabsorption of dietary carbohydrates can cause irritable bowel syndrome (IBS)-like symptoms including bloating, cramps and diarrhea. But according to Robert J. Shulman, MD, these symptoms may have less to do with the inability to absorb these substances and more to do with how the individual …

Individuals with low gut bacterial richness have more adiposity and a more pronounced inflammatory phenotype; and weight loss intervention can improve bacterial gene richness, according to two studies published in the Aug. 29 issue of Nature.

Sucampo and Takeda announced that the FDA has approved the supplemental New Drug Application (sNDA) for Amitiza (lubiprostone) for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain.

The FDA has determined that a Risk Evaluation and Mitigation Strategy (REMS) is necessary to ensure that the benefits of Bydureon (exenatide extended-release for injectable suspension; Amylin) outweigh the potential risks including  medullary thyroid carcinoma (MTC) and acute pancreatitis.

A recent study published in JAMA Internal Medicine concluded that treatment with the GLP-1 based therapies sitagliptin and exenatide in adults with type 2 diabetes mellitus was associated with increased odds of hospitalization for acute pancreatitis.